SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-QT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001213900-22-016230
Filing Date
2022-03-30
Accepted
2022-03-30 17:00:58
Documents
45
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 TRANSITION REPORT f10qt1221_oramedpharma.htm   iXBRL 10-QT 432544
2 CERTIFICATION f10qt1221ex31-1_oramedpharma.htm EX-31.1 9678
3 CERTIFICATION f10qt1221ex31-2_oramedpharma.htm EX-31.2 9466
4 CERTIFICATION f10qt1221ex32-1_oramedpharma.htm EX-32.1 3757
5 CERTIFICATION f10qt1221ex32-2_oramedpharma.htm EX-32.2 3564
  Complete submission text file 0001213900-22-016230.txt   2975116

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20211231.xsd EX-101.SCH 37287
7 XBRL CALCULATION FILE ormp-20211231_cal.xml EX-101.CAL 28723
8 XBRL DEFINITION FILE ormp-20211231_def.xml EX-101.DEF 168015
9 XBRL LABEL FILE ormp-20211231_lab.xml EX-101.LAB 339748
10 XBRL PRESENTATION FILE ormp-20211231_pre.xml EX-101.PRE 172055
39 EXTRACTED XBRL INSTANCE DOCUMENT f10qt1221_oramedpharma_htm.xml XML 266800
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-QT | Act: 34 | File No.: 001-35813 | Film No.: 22787372
SIC: 2834 Pharmaceutical Preparations